These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

409 related items for PubMed ID: 23375620

  • 1. Clinical manifestations and outcome of anti-PL7 positive patients with antisynthetase syndrome.
    Marie I, Josse S, Decaux O, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Hachulla E, Vittecoq O, Menard JF, Jouen F, Dominique S.
    Eur J Intern Med; 2013 Jul; 24(5):474-9. PubMed ID: 23375620
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients.
    Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF.
    Arthritis Rheum; 2011 Nov; 63(11):3439-47. PubMed ID: 21702020
    [Abstract] [Full Text] [Related]

  • 4. Comparison of long-term outcome between anti-Jo1- and anti-PL7/PL12 positive patients with antisynthetase syndrome.
    Marie I, Josse S, Decaux O, Dominique S, Diot E, Landron C, Roblot P, Jouneau S, Hatron PY, Tiev KP, Vittecoq O, Noel D, Mouthon L, Menard JF, Jouen F.
    Autoimmun Rev; 2012 Aug; 11(10):739-45. PubMed ID: 22326685
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.
    Hervier B, Devilliers H, Stanciu R, Meyer A, Uzunhan Y, Masseau A, Dubucquoi S, Hatron PY, Musset L, Wallaert B, Nunes H, Maisonobe T, Olsson NO, Adoue D, Arlet P, Sibilia J, Guiguet M, Lauque D, Amoura Z, Hachulla E, Hamidou M, Benveniste O.
    Autoimmun Rev; 2012 Dec; 12(2):210-7. PubMed ID: 22771754
    [Abstract] [Full Text] [Related]

  • 7. Outcome of anti-PL12 positive patients with antisynthetase syndrome.
    Marie I, Josse S, Decaux O, Dominique S, Landron C, Roblot P, Jouneau S, Vittecoq O, Jouen F.
    Presse Med; 2013 Jun; 42(6 Pt 1):e153-8. PubMed ID: 23428662
    [Abstract] [Full Text] [Related]

  • 8. Clinical Profiles and Prognosis of Patients with Distinct Antisynthetase Autoantibodies.
    Shi J, Li S, Yang H, Zhang Y, Peng Q, Lu X, Wang G.
    J Rheumatol; 2017 Jul; 44(7):1051-1057. PubMed ID: 28461650
    [Abstract] [Full Text] [Related]

  • 9. Short-term and long-term outcome of anti-Jo1-positive patients with anti-Ro52 antibody.
    Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF, Levesque H, Jouen F.
    Semin Arthritis Rheum; 2012 Jun; 41(6):890-9. PubMed ID: 22078416
    [Abstract] [Full Text] [Related]

  • 10. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China.
    Zhan X, Yan W, Wang Y, Li Q, Shi X, Gao Y, Ye Q.
    BMC Pulm Med; 2021 Feb 12; 21(1):57. PubMed ID: 33579248
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome.
    Liu H, Xie S, Liang T, Ma L, Sun H, Dai H, Wang C.
    Eur Radiol; 2019 Oct 12; 29(10):5349-5357. PubMed ID: 30919069
    [Abstract] [Full Text] [Related]

  • 13. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
    Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Taguchi Y, Hatta K, Noma S, Kobashi Y, Yoshizawa A, Oga T, Hirai T, Chin K, Nagai S, Izumi T, Mimori T, Mishima M.
    Respir Med; 2017 Jun 12; 127():57-64. PubMed ID: 28461123
    [Abstract] [Full Text] [Related]

  • 14. Clinical manifestations of skin, lung and muscle diseases in dermatomyositis positive for anti-aminoacyl tRNA synthetase antibodies.
    Fukamatsu H, Hirai Y, Miyake T, Kaji T, Morizane S, Yokoyama E, Hamada T, Oono T, Koyama Y, Norikane S, Iwatsuki K.
    J Dermatol; 2019 Oct 12; 46(10):886-897. PubMed ID: 31418479
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase.
    Hirakata M, Suwa A, Takada T, Sato S, Nagai S, Genth E, Song YW, Mimori T, Targoff IN.
    Arthritis Rheum; 2007 Apr 12; 56(4):1295-303. PubMed ID: 17393393
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cyclosporine in anti-Jo1-positive patients with corticosteroid-refractory interstitial lung disease.
    Cavagna L, Caporali R, Abdì-Alì L, Dore R, Meloni F, Montecucco C.
    J Rheumatol; 2013 Apr 12; 40(4):484-92. PubMed ID: 23418387
    [Abstract] [Full Text] [Related]

  • 20. Antisynthetase syndrome with anti-Jo1 antibodies in 48 patients: pulmonary involvement predicts disease-modifying antirheumatic drug use.
    Stanciu R, Guiguet M, Musset L, Touitou D, Beigelman C, Rigolet A, Costedoat-Chalumeau N, Allenbach Y, Hervier B, Dubourg O, Maisonobe T, Charuel JL, Behin A, Herson S, Amoura Z, Grenier P, Benveniste O.
    J Rheumatol; 2012 Sep 12; 39(9):1835-9. PubMed ID: 22859355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.